<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03172897</url>
  </required_header>
  <id_info>
    <org_study_id>2017[1319]</org_study_id>
    <nct_id>NCT03172897</nct_id>
  </id_info>
  <brief_title>Low-dose Dexmedetomidine in Mechanically Ventilated ICU Patients</brief_title>
  <official_title>Low-dose Dexmedetomidine for Delirium Prevention in Mechanically Ventilated Patients in Intensive Care Unit: a Multicenter, Randomised, Double-blinded, Placebo-controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Peking University First Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Peking University Third Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Peking University First Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      For patients undergoing mechanical ventilation, light sedation is better than deep sedation
      for the outcomes, which is manifested as shortened length of ICU stay, shortened duration of
      mechanical ventilation, and decreased mortality. In a recent study of the investigators,
      low-dose dexmedetomidine without sedative effects (0.1 ug/kg/h) improved sleep quality and
      reduced the incidence of delirium in elderly patients admitted to the ICU after surgery. The
      investigators hypothesize that, for ICU patients with prolonged mechanical ventilation,
      low-dose dexmedetomidine infusion (0.1 ug/kg/h) may also be effective in decreasing delirium.
      The purpose of this study is to investigate whether low-dose dexmedetomidine infusion can
      reduce the incidence of delirium in ICU patients with prolonged duration of mechanical
      ventilation (&gt;= 24 hours).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Delirium is an acutely occurred and transient brain dysfunction characterized with cognitive
      dysfunction, lowered consciousness, disturbed attention, abnormal psychoactivity, and
      disordered sleep-wake rhythm. Delirium is frequent in mechanically ventilated patients in the
      intensive care unit (ICU), with reported incidences up to 70% or 87%. Possible reasons
      leading to delirium include the intervention-heavy environment of the ICU, mechanical
      ventilation and sleep disturbances. The occurrence of delirium is associated with worse
      outcomes including prolonged mechanical ventilation and ICU stay, increased complications,
      prolonged hospital stay, higher mortality, and elevated medical expenses. It is also
      associated with worse long-term outcomes including declined cognitive function, lowered life
      quality, and elevated long-term mortality.

      Dexmedetomidine is a high selective alpha-2 adrenoceptor agonist with anxiolytic, sedative
      and analgesic effects. When used for sedation in mechanically ventilated patients (dose range
      0.2-1.4 ug/kg/h), it reduces the consumption of other sedatives and analgesics, ameliorates
      the rhythm and structure of sleep, and decreases the occurrence of delirium. In recent
      studies of the investigators, low-dose dexmedetomidine infusion (0.1 ug/kg/h) ameliorated
      sleep quality; for elderly patients admitted to the ICU after surgery, prophylactic low-dose
      dexmedetomidine infusion reduced the incidence of delirium (for patients with mechanical
      ventilation: 28.8% with placebo vs. 11.5% with dexmedetomidine, P&lt;0.0001; for patients
      without mechanical ventilation: 15.1% with placebo vs. 6.3% with dexmedetomidine, P=0.014).

      For patients undergoing mechanical ventilation, light sedation is better than deep sedation
      for the outcomes, which is manifested as shortened length of ICU stay, shortened duration of
      mechanical ventilation, and decreased mortality. Some authors even reported that no sedation
      (analgesia only) provides better outcome than light sedation, because it further shortens the
      durations of mechanical ventilation and ICU stay. In the above studies of the investigators,
      the recruited patients were less severe because the Acute Physiology and Chronic Health
      Evaluation II (APACHE II) score was low (mean score from 10.2 to 10.6) and the duration of
      mechanical ventilation was short (median 6.9 hours in the control group). The investigators
      hypothesize that, for ICU patients with prolonged mechanical ventilation, low-dose
      dexmedetomidine infusion (0.1 ug/kg/h) may also be effective in improving sleep and
      decreasing delirium. The purpose of this study is to investigate whether low-dose
      dexmedetomidine infusion can reduce the incidence of delirium in ICU patients with prolonged
      duration of mechanical ventilation (&gt;= 24 hours).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 20, 2017</start_date>
  <completion_date type="Anticipated">October 31, 2018</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2018</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Incidence of delirium within the first 7 days after enrollment</measure>
    <time_frame>From enrollment until 7 days.</time_frame>
    <description>Assessment twice daily (in the morning from 0600 h to 1000 h and in the evening from 1800 h to 2000 h) with the Confusion Assessment Method for the ICU (CAM-ICU).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Duration of mechanical ventilation</measure>
    <time_frame>From enrollment until extubation or 30 days.</time_frame>
    <description>Duration of mechanical ventilation after study enrollment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the ICU</measure>
    <time_frame>From enrollment until ICU discharge or 30 days.</time_frame>
    <description>Length of stay in the ICU after study enrollment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Length of stay in the hospital</measure>
    <time_frame>From enrollment until hospital discharge or 30 days.</time_frame>
    <description>Length of stay in the hospital after study enrollment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Occurrence of non-delirium complications</measure>
    <time_frame>From enrollment until 30 days.</time_frame>
    <description>Occurrence of complications other than delirium after study enrollment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All-cause 30-day mortality</measure>
    <time_frame>On the 30th day after enrollment.</time_frame>
    <description>All-cause 30-day mortality after study enrollment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day cognitive function</measure>
    <time_frame>On the 30th day after enrollment.</time_frame>
    <description>Assessed with the Telephone Interview of Cognitive Status-Modified (TICS-m).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>30-day life quality</measure>
    <time_frame>On the 30th day after enrollment.</time_frame>
    <description>Assessed with the WHOQOL-Bref.</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Pain intensity</measure>
    <time_frame>From enrollment until 7 days.</time_frame>
    <description>Assessed twice daily (in the morning from 0600 h to 1000 h and in the evening from 1800 h to 2000 h) with the Numeric Rating Scale (NRS, an 11 point scale where 0 indicated no pain and 10 indicated the worst possible pain).</description>
  </other_outcome>
  <other_outcome>
    <measure>Subjective sleep quality</measure>
    <time_frame>From enrollment until 7 days.</time_frame>
    <description>Assessed in the morning with the NRS (an 11 point scale where 0 indicated the best possible sleep and 10 indicated the worst possible sleep).</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">260</enrollment>
  <condition>Adult Disease</condition>
  <condition>Intensive Care Unit Syndrome</condition>
  <condition>Mechanical Ventilation Complication</condition>
  <condition>Delirium</condition>
  <condition>Dexmedetomidine</condition>
  <arm_group>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Dexmedetomidine is infused at a rate of 0.1 ug/kg/h for a maximum of 3 days.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo (normal saline) is infused at a same rate as in the dexmedetomidine group for a maximum of 3 days.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexmedetomidine</intervention_name>
    <description>Dexmedetomidine is administered as a continuous intravenous infusion at a rate of 0.025 mL/kg per h (0.1 μg/kg per h) from study recruitment in the ICU for no more than 72 hours.</description>
    <arm_group_label>Dexmedetomidine group</arm_group_label>
    <other_name>Dexmedetomidine hydrochloride</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo (normal saline)</intervention_name>
    <description>Placebo (normal saline) is administered as a continuous intravenous infusion at a rate of 0.025 mL/kg per h from study recruitment in the ICU for no more than 72 hours.</description>
    <arm_group_label>Placebo group</arm_group_label>
    <other_name>Normal saline</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  aged 18 years or older;

          -  admitted to the ICU;

          -  with expected duration of mechanical ventilation of more than 24 hours.

        Exclusion Criteria:

          -  refused to participate;

          -  aged less than 18 years;

          -  pregnant;

          -  preoperative history of schizophrenia, epilepsy, Parkinsonism, or myasthenia gravis;

          -  inability to communicate in the preoperative period (coma, profound dementia, or
             language barrier);

          -  brain injury or neurosurgery;

          -  known preoperative left ventricular ejection fraction less than 30%, sick sinus
             syndrome, severe sinus bradycardia (&lt;50 beats per min [bpm]), or second degree or
             greater atrioventricular block without pacemaker;

          -  severe hepatic dysfunction (Child-Pugh class C);

          -  severe renal dysfunction (undergoing dialysis before surgery);

          -  less likely to survive for more than 24 hours.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dong-Xin Wang, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Peking University First Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Dong-Xin Wang, MD, PhD</last_name>
    <phone>86 10 83572784</phone>
    <email>wangdongxin@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Shuang-Ling Li, MD</last_name>
    <phone>+86 13661355069</phone>
    <email>lishuangling888@hotmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100034</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Dong-Xin Wang, MD, PhD</last_name>
      <phone>8610 83572784</phone>
      <email>wangdongxin@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Shuang-Ling Li, MD</last_name>
      <phone>+86 13661355069</phone>
      <email>lishuangling888@hotmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Nedergaard HK, Jensen HI, Stylsvig M, Lauridsen JT, Toft P. Non-sedation versus sedation with a daily wake-up trial in critically ill patients recieving mechanical ventilation - effects on long-term cognitive function: Study protocol for a randomized controlled trial, a substudy of the NONSEDA trial. Trials. 2016 Jun 1;17(1):269. doi: 10.1186/s13063-016-1390-5.</citation>
    <PMID>27250658</PMID>
  </reference>
  <reference>
    <citation>Nedergaard HK, Jensen HI, Lauridsen JT, Sjøgaard G, Toft P. Non-sedation versus sedation with a daily wake-up trial in critically ill patients receiving mechanical ventilation--effects on physical function: study protocol for a randomized controlled trial: a substudy of the NONSEDA trial. Trials. 2015 Jul 23;16:310. doi: 10.1186/s13063-015-0856-1.</citation>
    <PMID>26201718</PMID>
  </reference>
  <reference>
    <citation>Toft P, Olsen HT, Jørgensen HK, Strøm T, Nibro HL, Oxlund J, Wian KA, Ytrebø LM, Kroken BA, Chew M. Non-sedation versus sedation with a daily wake-up trial in critically ill patients receiving mechanical ventilation (NONSEDA Trial): study protocol for a randomised controlled trial. Trials. 2014 Dec 20;15:499. doi: 10.1186/1745-6215-15-499.</citation>
    <PMID>25528350</PMID>
  </reference>
  <reference>
    <citation>Strøm T, Martinussen T, Toft P. A protocol of no sedation for critically ill patients receiving mechanical ventilation: a randomised trial. Lancet. 2010 Feb 6;375(9713):475-80. doi: 10.1016/S0140-6736(09)62072-9. Epub 2010 Jan 29.</citation>
    <PMID>20116842</PMID>
  </reference>
  <reference>
    <citation>Porhomayon J, Joude P, Adlparvar G, El-Solh AA, Nader ND. The Impact of High Versus Low Sedation Dosing Strategy on Cognitive Dysfunction in Survivors of Intensive Care Units: A Systematic Review and Meta-Analysis. J Cardiovasc Thorac Res. 2015;7(2):43-8. doi: 10.15171/jcvtr.2015.10. Review.</citation>
    <PMID>26191390</PMID>
  </reference>
  <reference>
    <citation>Balzer F, Weiß B, Kumpf O, Treskatsch S, Spies C, Wernecke KD, Krannich A, Kastrup M. Early deep sedation is associated with decreased in-hospital and two-year follow-up survival. Crit Care. 2015 Apr 28;19:197. doi: 10.1186/s13054-015-0929-2.</citation>
    <PMID>25928417</PMID>
  </reference>
  <reference>
    <citation>Treggiari MM, Romand JA, Yanez ND, Deem SA, Goldberg J, Hudson L, Heidegger CP, Weiss NS. Randomized trial of light versus deep sedation on mental health after critical illness. Crit Care Med. 2009 Sep;37(9):2527-34. doi: 10.1097/CCM.0b013e3181a5689f.</citation>
    <PMID>19602975</PMID>
  </reference>
  <reference>
    <citation>Hughes CG, Girard TD, Pandharipande PP. Daily sedation interruption versus targeted light sedation strategies in ICU patients. Crit Care Med. 2013 Sep;41(9 Suppl 1):S39-45. doi: 10.1097/CCM.0b013e3182a168c5. Review. Erratum in: Crit Care Med. 2013 Nov;41(11):e400.</citation>
    <PMID>23989094</PMID>
  </reference>
  <reference>
    <citation>Su X, Meng ZT, Wu XH, Cui F, Li HL, Wang DX, Zhu X, Zhu SN, Maze M, Ma D. Dexmedetomidine for prevention of delirium in elderly patients after non-cardiac surgery: a randomised, double-blind, placebo-controlled trial. Lancet. 2016 Oct 15;388(10054):1893-1902. doi: 10.1016/S0140-6736(16)30580-3. Epub 2016 Aug 16.</citation>
    <PMID>27542303</PMID>
  </reference>
  <reference>
    <citation>Wu XH, Cui F, Zhang C, Meng ZT, Wang DX, Ma J, Wang GF, Zhu SN, Ma D. Low-dose Dexmedetomidine Improves Sleep Quality Pattern in Elderly Patients after Noncardiac Surgery in the Intensive Care Unit: A Pilot Randomized Controlled Trial. Anesthesiology. 2016 Nov;125(5):979-991.</citation>
    <PMID>27571256</PMID>
  </reference>
  <reference>
    <citation>Xia ZQ, Chen SQ, Yao X, Xie CB, Wen SH, Liu KX. Clinical benefits of dexmedetomidine versus propofol in adult intensive care unit patients: a meta-analysis of randomized clinical trials. J Surg Res. 2013 Dec;185(2):833-43. doi: 10.1016/j.jss.2013.06.062. Epub 2013 Jul 24. Review.</citation>
    <PMID>23910886</PMID>
  </reference>
  <reference>
    <citation>Pandharipande PP, Pun BT, Herr DL, Maze M, Girard TD, Miller RR, Shintani AK, Thompson JL, Jackson JC, Deppen SA, Stiles RA, Dittus RS, Bernard GR, Ely EW. Effect of sedation with dexmedetomidine vs lorazepam on acute brain dysfunction in mechanically ventilated patients: the MENDS randomized controlled trial. JAMA. 2007 Dec 12;298(22):2644-53.</citation>
    <PMID>18073360</PMID>
  </reference>
  <reference>
    <citation>Wunsch H, Kahn JM, Kramer AA, Wagener G, Li G, Sladen RN, Rubenfeld GD. Dexmedetomidine in the care of critically ill patients from 2001 to 2007: an observational cohort study. Anesthesiology. 2010 Aug;113(2):386-94. doi: 10.1097/ALN.0b013e3181e74116.</citation>
    <PMID>20613466</PMID>
  </reference>
  <reference>
    <citation>Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, Bratty JR, Takala J; Dexmedetomidine for Long-Term Sedation Investigators. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials. JAMA. 2012 Mar 21;307(11):1151-60. doi: 10.1001/jama.2012.304.</citation>
    <PMID>22436955</PMID>
  </reference>
  <reference>
    <citation>Djaiani G, Silverton N, Fedorko L, Carroll J, Styra R, Rao V, Katznelson R. Dexmedetomidine versus Propofol Sedation Reduces Delirium after Cardiac Surgery: A Randomized Controlled Trial. Anesthesiology. 2016 Feb;124(2):362-8. doi: 10.1097/ALN.0000000000000951.</citation>
    <PMID>26575144</PMID>
  </reference>
  <reference>
    <citation>Mo Y, Zimmermann AE. Role of dexmedetomidine for the prevention and treatment of delirium in intensive care unit patients. Ann Pharmacother. 2013 Jun;47(6):869-76. doi: 10.1345/aph.1AR708. Review.</citation>
    <PMID>23719785</PMID>
  </reference>
  <reference>
    <citation>Pisani MA, Kong SY, Kasl SV, Murphy TE, Araujo KL, Van Ness PH. Days of delirium are associated with 1-year mortality in an older intensive care unit population. Am J Respir Crit Care Med. 2009 Dec 1;180(11):1092-7. doi: 10.1164/rccm.200904-0537OC. Epub 2009 Sep 10.</citation>
    <PMID>19745202</PMID>
  </reference>
  <reference>
    <citation>Bickel H, Gradinger R, Kochs E, Förstl H. High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study. Dement Geriatr Cogn Disord. 2008;26(1):26-31. doi: 10.1159/000140804. Epub 2008 Jun 24.</citation>
    <PMID>18577850</PMID>
  </reference>
  <reference>
    <citation>Van Rompaey B, Schuurmans MJ, Shortridge-Baggett LM, Truijen S, Elseviers M, Bossaert L. Long term outcome after delirium in the intensive care unit. J Clin Nurs. 2009 Dec;18(23):3349-57. doi: 10.1111/j.1365-2702.2009.02933.x. Epub 2009 Sep 4.</citation>
    <PMID>19735334</PMID>
  </reference>
  <reference>
    <citation>Abelha FJ, Luís C, Veiga D, Parente D, Fernandes V, Santos P, Botelho M, Santos A, Santos C. Outcome and quality of life in patients with postoperative delirium during an ICU stay following major surgery. Crit Care. 2013 Oct 29;17(5):R257. doi: 10.1186/cc13084.</citation>
    <PMID>24168808</PMID>
  </reference>
  <reference>
    <citation>Milbrandt EB, Deppen S, Harrison PL, Shintani AK, Speroff T, Stiles RA, Truman B, Bernard GR, Dittus RS, Ely EW. Costs associated with delirium in mechanically ventilated patients. Crit Care Med. 2004 Apr;32(4):955-62.</citation>
    <PMID>15071384</PMID>
  </reference>
  <reference>
    <citation>Franco K, Litaker D, Locala J, Bronson D. The cost of delirium in the surgical patient. Psychosomatics. 2001 Jan-Feb;42(1):68-73.</citation>
    <PMID>11161124</PMID>
  </reference>
  <reference>
    <citation>Ely EW, Shintani A, Truman B, Speroff T, Gordon SM, Harrell FE Jr, Inouye SK, Bernard GR, Dittus RS. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004 Apr 14;291(14):1753-62.</citation>
    <PMID>15082703</PMID>
  </reference>
  <reference>
    <citation>Ansaloni L, Catena F, Chattat R, Fortuna D, Franceschi C, Mascitti P, Melotti RM. Risk factors and incidence of postoperative delirium in elderly patients after elective and emergency surgery. Br J Surg. 2010 Feb;97(2):273-80. doi: 10.1002/bjs.6843.</citation>
    <PMID>20069607</PMID>
  </reference>
  <reference>
    <citation>Ely EW, Gautam S, Margolin R, Francis J, May L, Speroff T, Truman B, Dittus R, Bernard R, Inouye SK. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001 Dec;27(12):1892-900. Epub 2001 Nov 8.</citation>
    <PMID>11797025</PMID>
  </reference>
  <reference>
    <citation>Balas MC, Happ MB, Yang W, Chelluri L, Richmond T. Outcomes Associated With Delirium in Older Patients in Surgical ICUs. Chest. 2009 Jan;135(1):18-25. doi: 10.1378/chest.08-1456. Epub 2008 Nov 18.</citation>
    <PMID>19017895</PMID>
  </reference>
  <reference>
    <citation>Roberts B, Rickard CM, Rajbhandari D, Turner G, Clarke J, Hill D, Tauschke C, Chaboyer W, Parsons R. Multicentre study of delirium in ICU patients using a simple screening tool. Aust Crit Care. 2005 Feb;18(1):6, 8-9, 11-4 passim.</citation>
    <PMID>18038529</PMID>
  </reference>
  <reference>
    <citation>Scott BK. Disruption of Circadian Rhythms and Sleep in Critical Illness and its Impact on the Development of Delirium. Curr Pharm Des. 2015;21(24):3443-52. Review.</citation>
    <PMID>26144937</PMID>
  </reference>
  <reference>
    <citation>Francis J, Kapoor WN. Prognosis after hospital discharge of older medical patients with delirium. J Am Geriatr Soc. 1992 Jun;40(6):601-6.</citation>
    <PMID>1587979</PMID>
  </reference>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 17, 2017</study_first_submitted>
  <study_first_submitted_qc>May 31, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 1, 2017</study_first_posted>
  <last_update_submitted>May 31, 2017</last_update_submitted>
  <last_update_submitted_qc>May 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">June 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Peking University First Hospital</investigator_affiliation>
    <investigator_full_name>Dong-Xin Wang</investigator_full_name>
    <investigator_title>Professor and Chairman, Department of Anesthesiology and Critical Care Medicine</investigator_title>
  </responsible_party>
  <keyword>Adult</keyword>
  <keyword>Intensive care unit</keyword>
  <keyword>Mechanical ventilation</keyword>
  <keyword>Delirium</keyword>
  <keyword>Dexmedetomidine</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Delirium</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexmedetomidine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

